Freda Benjamin J, Knee Alexander B, Braden Gregory L, Visintainer Paul F, Thakar Charuhas V
Department of Medicine, Baystate Wing Hospital, Palmer, Massachusetts.
Division of Academic Affairs, Epidemiology/Biostatistics Research Core, Springfield, Massachusetts.
Am J Cardiol. 2017 Jun 1;119(11):1809-1814. doi: 10.1016/j.amjcard.2017.02.044. Epub 2017 Mar 16.
Although acute kidney injury (AKI) is common in heart failure, yet the impact of the onset, timing, and duration of AKI on short-term outcomes is not well studied. AKI was defined as an increase in serum creatinine SCr of ≥0.3 mg/dl or 1.5 times relative to the admission and further categorized as transient AKI (T-AKI: SCr returning to within 10% of baseline); sustained AKI (S-AKI: those with at least 72 hours of hospital stay and did not meet T-AKI); and unknown duration AKI (U-AKI: those with less than 72 hours stay and did not meet T-AKI). Reference category was no AKI (stable or <0.3 mg/dl change in SCr). The main outcome was 30-day all-cause hospital readmission. Unadjusted and adjusted association between AKI category of interest and main outcome was represented as percent and relative risks with 95% CIs. Statistical significance was set at an alpha of 0.05. From the Cerner Health Facts sample, 14,017 of 22,059 available subjects met the eligibility criteria. Approximately, 19.2% of our sample met the primary outcome. Compared with no AKI (readmission rate of 17.7%; 95% CI 16.4% to 18.9%), the adjusted rate of readmission was highest in patients with S-AKI (22.8%, 95% CI 20.8% to 24.8%; p <0.001), followed by 20.2% (95% CI 17.5% to 22.8%; p = 0.05) in T-AKI patients. Compared with no AKI, the adjusted relative risk of 30-day readmission was 1.29 (95% CI 1.17 to 1.42), 1.14 (95% CI 1.00 to 1.31), and 1.12 (95% CI, 1.01 to 1.26) in S-AKI, T-AKI, and U-AKI, respectively. In conclusion, both sustained AKI and patients with transient elevation still remain at a higher risk of readmission within 30 days. Future studies should focus on examining process-of-care after discharge in patients with different patterns of AKI.
虽然急性肾损伤(AKI)在心力衰竭患者中很常见,但AKI的发病、发生时间及持续时间对短期预后的影响尚未得到充分研究。AKI定义为血清肌酐(SCr)较入院时升高≥0.3mg/dl或升高至入院时的1.5倍,并进一步分为短暂性AKI(T-AKI:SCr恢复至基线水平的10%以内);持续性AKI(S-AKI:住院至少72小时且不符合T-AKI标准者);以及持续时间不明的AKI(U-AKI:住院时间少于72小时且不符合T-AKI标准者)。参考类别为无AKI(SCr稳定或变化<0.3mg/dl)。主要结局为30天全因再入院。将感兴趣的AKI类别与主要结局之间的未调整和调整后的关联表示为百分比和相对风险,并给出95%置信区间(CI)。设定统计学显著性水平α为0.05。在Cerner Health Facts样本中,22,059名可用受试者中有14,017名符合纳入标准。约19.2%的样本符合主要结局。与无AKI(再入院率为17.7%;95%CI为16.4%至18.9%)相比,S-AKI患者的调整后再入院率最高(22.8%,95%CI为20.8%至24.8%;p<0.001),其次是T-AKI患者,为20.2%(95%CI为17.5%至22.8%;p=0.05)。与无AKI相比,S-AKI、T-AKI和U-AKI患者30天再入院的调整后相对风险分别为1.29(95%CI为1.17至1.42)、1.14(95%CI为1.00至1.31)和1.12(95%CI为1.01至1.26)。总之,持续性AKI和短暂性升高的患者在30天内仍有较高的再入院风险。未来的研究应侧重于检查不同AKI模式患者出院后的护理过程。